Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsChildren and adolescents with venous thromboembolism, particularly children aged 4 years or younger, face a higher risk for mortality and economic burden.
Block reversal using sugammadex is associated with better respiratory outcomes than that using neostigmine in adults undergoing upper gastrointestinal endoscopic procedures, a study finds.
1.
On all CAR-T products, the FDA is calling for a new boxed warning.
2.
Survival is extended by a new treatment option for metastatic colorectal cancer.
3.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
4.
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.
5.
Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.
1.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
2.
Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies
3.
Progressive Techniques in Oncology in Daily Practice
4.
Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma
5.
Modern Standards in Oncology and Patient Outcomes
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge